{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:18:22Z","timestamp":1786979902799,"version":"build-2736575974"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82072028"],"award-info":[{"award-number":["82072028"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"DOI":"10.1007\/s00262-025-04003-5","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T09:15:59Z","timestamp":1743153359000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Microwave ablation combined with immune checkpoint inhibitor enhanced the antitumor immune activation and memory in rechallenged tumor mouse model"],"prefix":"10.1007","volume":"74","author":[{"given":"Fengkuo","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meixiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4906-7746","authenticated-orcid":false,"given":"Xin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,25]]},"reference":[{"key":"4003_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"4003_CR2","doi-asserted-by":"publisher","first-page":"249","DOI":"10.6004\/jnccn.2204.0023","volume":"22","author":"GJ Riely","year":"2024","unstructured":"Riely GJ, Wood DE, Ettinger DS et al (2024) Non-small cell lung cancer, version 4.2024, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 22:249\u2013274. https:\/\/doi.org\/10.6004\/jnccn.2204.0023","journal-title":"J Natl Compr Canc Netw"},{"key":"4003_CR3","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.230139","volume":"308","author":"M Elsayed","year":"2023","unstructured":"Elsayed M, Solomon SB (2023) Interventional oncology: 2043 and beyond. Radiology 308:e230139. https:\/\/doi.org\/10.1148\/radiol.230139","journal-title":"Radiology"},{"key":"4003_CR4","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.4103\/jcrt.jcrt_880_22","volume":"18","author":"X Ye","year":"2022","unstructured":"Ye X, Fan W, Wang Z et al (2022) Clinical practice guidelines on image-guided thermal ablation of primary and metastatic lung tumors (2022 edition). J Cancer Res Ther 18:1213\u201330. https:\/\/doi.org\/10.4103\/jcrt.jcrt_880_22","journal-title":"J Cancer Res Ther"},{"key":"4003_CR5","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.62347\/QJID8425","volume":"14","author":"F Xu","year":"2024","unstructured":"Xu F, Wei Z, Ye X (2024) Immunomodulatory effects of microwave ablation on malignant tumors. Am J Cancer Res 14:2714\u20132730. https:\/\/doi.org\/10.62347\/QJID8425","journal-title":"Am J Cancer Res"},{"key":"4003_CR6","doi-asserted-by":"publisher","first-page":"2842","DOI":"10.21037\/tlcr-20-1075","volume":"10","author":"K Rangamuwa","year":"2021","unstructured":"Rangamuwa K, Leong T, Weeden C et al (2021) Thermal ablation in non-small cell lung cancer: a review of treatment modalities and the evidence for combination with immune checkpoint inhibitors. Transl Lung Cancer Res 10:2842\u20132857. https:\/\/doi.org\/10.21037\/tlcr-20-1075","journal-title":"Transl Lung Cancer Res"},{"key":"4003_CR7","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.ymthe.2023.01.017","volume":"31","author":"L Xie","year":"2023","unstructured":"Xie L, Meng Z (2023) Immunomodulatory effect of locoregional therapy in the tumor microenvironment. Mol Ther 31:951\u2013969. https:\/\/doi.org\/10.1016\/j.ymthe.2023.01.017","journal-title":"Mol Ther"},{"key":"4003_CR8","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.4103\/jcrt.JCRT_1399_20","volume":"16","author":"H Xu","year":"2020","unstructured":"Xu H, Sun W, Kong Y, Huang Y, Wei Z, Zhang L, Liang J, Ye X (2020) Immune abscopal effect of microwave ablation for lung metastases of endometrial carcinoma. J Cancer Res Ther 16:1718\u20131721. https:\/\/doi.org\/10.4103\/jcrt.JCRT_1399_20","journal-title":"J Cancer Res Ther"},{"key":"4003_CR9","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1097\/01.sla.0000128305.90650.71","volume":"239","author":"EK Abdalla","year":"2004","unstructured":"Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR, Hess K, Curley SA (2004) Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection\/ablation for colorectal liver metastases. Ann Surg 239:818\u201325. https:\/\/doi.org\/10.1097\/01.sla.0000128305.90650.71","journal-title":"Ann Surg"},{"key":"4003_CR10","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1126\/science.aar4060","volume":"359","author":"A Ribas","year":"2018","unstructured":"Ribas A, Wolchok JD (2018) Cancer immunotherapy using checkpoint blockade. Science 359:1350\u20131355. https:\/\/doi.org\/10.1126\/science.aar4060","journal-title":"Science"},{"issue":"1582\u201397","key":"4003_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2024.08.007","volume":"42","author":"K Wang","year":"2024","unstructured":"Wang K, Coutifaris P, Brocks D et al (2024) Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8(+) T cells. Cancer Cell 42(1582\u201397):e10. https:\/\/doi.org\/10.1016\/j.ccell.2024.08.007","journal-title":"Cancer Cell"},{"key":"4003_CR12","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S0140-6736(24)01029-8","volume":"404","author":"ML Meyer","year":"2024","unstructured":"Meyer ML, Fitzgerald BG, Paz-Ares L, Cappuzzo F, Janne PA, Peters S, Hirsch FR (2024) New promises and challenges in the treatment of advanced non-small-cell lung cancer. Lancet 404:803\u2013822. https:\/\/doi.org\/10.1016\/S0140-6736(24)01029-8","journal-title":"Lancet"},{"key":"4003_CR13","doi-asserted-by":"publisher","first-page":"849","DOI":"10.4103\/jcrt.jcrt_723_23","volume":"19","author":"J Gao","year":"2023","unstructured":"Gao J, Zhang C, Wei Z, Ye X (2023) Immunotherapy for early-stage non-small cell lung cancer: a system review. J Cancer Res Ther 19:849\u2013865. https:\/\/doi.org\/10.4103\/jcrt.jcrt_723_23","journal-title":"J Cancer Res Ther"},{"key":"4003_CR14","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1097\/CM9.0000000000002750","volume":"136","author":"Y Li","year":"2023","unstructured":"Li Y, Liang X, Li H, Chen X (2023) Efficacy and safety of immune checkpoint inhibitors for advanced non-small cell lung cancer with or without PD-L1 selection: a systematic review and network meta-analysis. Chin Med J (Engl) 136:2156\u20132165. https:\/\/doi.org\/10.1097\/CM9.0000000000002750","journal-title":"Chin Med J (Engl)"},{"key":"4003_CR15","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1007\/s00330-019-06613-x","volume":"30","author":"Z Wei","year":"2020","unstructured":"Wei Z, Yang X, Ye X et al (2020) Microwave ablation plus chemotherapy versus chemotherapy in advanced non-small cell lung cancer: a multicenter, randomized, controlled, phase III clinical trial. Eur Radiol 30:2692\u20132702. https:\/\/doi.org\/10.1007\/s00330-019-06613-x","journal-title":"Eur Radiol"},{"key":"4003_CR16","doi-asserted-by":"publisher","first-page":"1097625","DOI":"10.3389\/fimmu.2022.1097625","volume":"13","author":"Q Shi","year":"2022","unstructured":"Shi Q, Zhou X, Zhang Z et al (2022) Microwave ablation and synchronous transarterial chemoembolization combined with PD-1 inhibitor in patients with hepatocellular carcinoma following tyrosine kinase inhibitor intolerance. Front Immunol 13:1097625. https:\/\/doi.org\/10.3389\/fimmu.2022.1097625","journal-title":"Front Immunol"},{"key":"4003_CR17","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1159\/000536518","volume":"13","author":"ZM Huang","year":"2024","unstructured":"Huang ZM, Han X, Wang J et al (2024) A prospective, single-arm, phase 2 study of modified transarterial chemoembolization using low-dose chemotherapy with blank microspheres plus low-dose lenvatinib and microwave ablation in patients with large (>\/=7 cm) unresectable hepatocellular carcinoma: The TALEM Trial. Liver Cancer 13:438\u2013450. https:\/\/doi.org\/10.1159\/000536518","journal-title":"Liver Cancer"},{"key":"4003_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2023.107259","volume":"182","author":"P Laeseke","year":"2023","unstructured":"Laeseke P, Ng C, Ferko N et al (2023) Stereotactic body radiation therapy and thermal ablation for treatment of NSCLC: a systematic literature review and meta-analysis. Lung Cancer 182:107259. https:\/\/doi.org\/10.1016\/j.lungcan.2023.107259","journal-title":"Lung Cancer"},{"key":"4003_CR19","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1186\/s12967-022-03646-7","volume":"20","author":"D Shao","year":"2022","unstructured":"Shao D, Chen Y, Huang H, Liu Y, Chen J, Zhu D, Zheng X, Chen L, Jiang J (2022) LAG3 blockade coordinates with microwave ablation to promote CD8(+) T cell-mediated anti-tumor immunity. J Transl Med 20:433. https:\/\/doi.org\/10.1186\/s12967-022-03646-7","journal-title":"J Transl Med"},{"key":"4003_CR20","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1158\/1078-0432.CCR-15-1352","volume":"22","author":"L Shi","year":"2016","unstructured":"Shi L, Chen L, Wu C et al (2016) PD-1 blockade boosts radiofrequency ablation-elicited adaptive immune responses against tumor. Clin Cancer Res 22:1173\u20131184. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-1352","journal-title":"Clin Cancer Res"},{"key":"4003_CR21","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41416-021-01404-y","volume":"125","author":"Y Ni","year":"2021","unstructured":"Ni Y, Peng J, Yang X, Wei Z, Zhai B, Chi J, Li X, Ye X (2021) Multicentre study of microwave ablation for pulmonary oligorecurrence after radical resection of non-small-cell lung cancer. Br J Cancer 125:672\u2013678. https:\/\/doi.org\/10.1038\/s41416-021-01404-y","journal-title":"Br J Cancer"},{"key":"4003_CR22","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s11547-023-01672-z","volume":"128","author":"Z Wei","year":"2023","unstructured":"Wei Z, Chi J, Cao P, Jin Y, Li X, Ye X (2023) Microwave ablation with a blunt-tip antenna for pulmonary ground-glass nodules: a retrospective, multicenter, case-control study. Radiol Med 128:1061\u20131069. https:\/\/doi.org\/10.1007\/s11547-023-01672-z","journal-title":"Radiol Med"},{"key":"4003_CR23","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.2147\/JIR.S462650","volume":"17","author":"J Sang","year":"2024","unstructured":"Sang J, Liu P, Wang M, Xu F, Ma J, Wei Z, Ye X (2024) Dynamic changes in the immune microenvironment in tumor-draining lymph nodes of a Lewis lung cancer mouse model after microwave ablation. J Inflamm Res 17:4175\u20134186. https:\/\/doi.org\/10.2147\/JIR.S462650","journal-title":"J Inflamm Res"},{"key":"4003_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2019.119490","volume":"224","author":"X Han","year":"2019","unstructured":"Han X, Wang R, Xu J et al (2019) In situ thermal ablation of tumors in combination with nano-adjuvant and immune checkpoint blockade to inhibit cancer metastasis and recurrence. Biomaterials 224:119490. https:\/\/doi.org\/10.1016\/j.biomaterials.2019.119490","journal-title":"Biomaterials"},{"key":"4003_CR25","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s40164-024-00520-8","volume":"13","author":"H Pan","year":"2024","unstructured":"Pan H, Tian Y, Pei S et al (2024) Combination of percutaneous thermal ablation and adoptive Th9 cell transfer therapy against non-small cell lung cancer. Exp Hematol Oncol 13:52. https:\/\/doi.org\/10.1186\/s40164-024-00520-8","journal-title":"Exp Hematol Oncol"},{"key":"4003_CR26","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s13046-024-03122-8","volume":"43","author":"D Sun","year":"2024","unstructured":"Sun D, Tan L, Chen Y et al (2024) CXCL5 impedes CD8(+) T cell immunity by upregulating PD-L1 expression in lung cancer via PXN\/AKT signaling phosphorylation and neutrophil chemotaxis. J Exp Clin Cancer Res 43:202. https:\/\/doi.org\/10.1186\/s13046-024-03122-8","journal-title":"J Exp Clin Cancer Res"},{"key":"4003_CR27","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.tcb.2020.06.003","volume":"30","author":"M St Paul","year":"2020","unstructured":"St Paul M, Ohashi PS (2020) The roles of CD8(+) T cell subsets in antitumor immunity. Trends Cell Biol 30:695\u2013704. https:\/\/doi.org\/10.1016\/j.tcb.2020.06.003","journal-title":"Trends Cell Biol"},{"issue":"107\u201324","key":"4003_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2022.12.002","volume":"56","author":"N Prokhnevska","year":"2023","unstructured":"Prokhnevska N, Cardenas MA, Valanparambil RM et al (2023) CD8(+) T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor. Immunity 56(107\u201324):e5. https:\/\/doi.org\/10.1016\/j.immuni.2022.12.002","journal-title":"Immunity"},{"key":"4003_CR29","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/s43018-024-00734-z","volume":"5","author":"O Barboy","year":"2024","unstructured":"Barboy O, Bercovich A, Li H et al (2024) Modeling T cell temporal response to cancer immunotherapy rationalizes development of combinatorial treatment protocols. Nat Cancer 5:742\u2013759. https:\/\/doi.org\/10.1038\/s43018-024-00734-z","journal-title":"Nat Cancer"},{"key":"4003_CR30","doi-asserted-by":"publisher","first-page":"6922","DOI":"10.1038\/s41467-024-51386-7","volume":"15","author":"D Liu","year":"2024","unstructured":"Liu D, Yan J, Ma F, Wang J, Yan S, He W (2024) Reinvigoration of cytotoxic T lymphocytes in microsatellite instability-high colon adenocarcinoma through lysosomal degradation of PD-L1. Nat Commun 15:6922. https:\/\/doi.org\/10.1038\/s41467-024-51386-7","journal-title":"Nat Commun"},{"key":"4003_CR31","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.trecan.2023.09.006","volume":"10","author":"I Delclaux","year":"2024","unstructured":"Delclaux I, Ventre KS, Jones D, Lund AW (2024) The tumor-draining lymph node as a reservoir for systemic immune surveillance. Trends Cancer 10:28\u201337. https:\/\/doi.org\/10.1016\/j.trecan.2023.09.006","journal-title":"Trends Cancer"},{"key":"4003_CR32","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.trecan.2018.09.001","volume":"4","author":"JP Bottcher","year":"2018","unstructured":"Bottcher JP, Reis e Sousa C (2018) The role of type 1 conventional dendritic cells in cancer immunity. Trends Cancer. 4:784\u201392. https:\/\/doi.org\/10.1016\/j.trecan.2018.09.001","journal-title":"Trends Cancer."},{"key":"4003_CR33","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/978-1-0716-2938-3_5","volume":"2618","author":"G Pasqual","year":"2023","unstructured":"Pasqual G, Chudnovskiy A, Victora GD (2023) Monitoring the interaction between dendritic cells and T cells in vivo with LIPSTIC. Methods Mol Biol 2618:71\u201380. https:\/\/doi.org\/10.1007\/978-1-0716-2938-3_5","journal-title":"Methods Mol Biol"},{"key":"4003_CR34","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s00262-024-03718-1","volume":"73","author":"S Wu","year":"2024","unstructured":"Wu S, Jiang H, Fang Z et al (2024) Enhanced abscopal anti-tumor response via a triple combination of thermal ablation, IL-21, and PD-1 inhibition therapy. Cancer Immunol Immunother 73:138. https:\/\/doi.org\/10.1007\/s00262-024-03718-1","journal-title":"Cancer Immunol Immunother"},{"issue":"213\u201331","key":"4003_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2024.12.001","volume":"43","author":"S Ma","year":"2025","unstructured":"Ma S, Ong LT, Jiang Z et al (2025) Targeting P4HA1 promotes CD8(+) T cell progenitor expansion toward immune memory and systemic anti-tumor immunity. Cancer Cell 43(213\u201331):e9. https:\/\/doi.org\/10.1016\/j.ccell.2024.12.001","journal-title":"Cancer Cell"},{"key":"4003_CR36","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.4103\/jcrt.jcrt_1436_23","volume":"19","author":"X Yang","year":"2023","unstructured":"Yang X, Jin Y, Lin Z et al (2023) Microwave ablation for the treatment of peripheral ground-glass nodule-like lung cancer: long-term results from a multi-center study. J Cancer Res Ther 19:1001\u20131010. https:\/\/doi.org\/10.4103\/jcrt.jcrt_1436_23","journal-title":"J Cancer Res Ther"},{"key":"4003_CR37","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1111\/cas.16182","volume":"115","author":"N He","year":"2024","unstructured":"He N, Huang H, Wu S et al (2024) Microwave ablation combined with PD-L1 blockade synergistically promotes Cxcl9-mediated antitumor immunity. Cancer Sci 115:2196\u20132208. https:\/\/doi.org\/10.1111\/cas.16182","journal-title":"Cancer Sci"},{"key":"4003_CR38","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1080\/15384101.2022.2112007","volume":"22","author":"RQ Guo","year":"2023","unstructured":"Guo RQ, Peng JZ, Li YM, Li XG (2023) Microwave ablation combined with anti-PD-1\/CTLA-4 therapy induces an antitumor immune response to renal cell carcinoma in a murine model. Cell Cycle 22:242\u2013254. https:\/\/doi.org\/10.1080\/15384101.2022.2112007","journal-title":"Cell Cycle"},{"key":"4003_CR39","doi-asserted-by":"publisher","first-page":"6203","DOI":"10.1038\/s41467-022-33968-5","volume":"13","author":"B Cao","year":"2022","unstructured":"Cao B, Liu M, Wang L et al (2022) Remodelling of tumour microenvironment by microwave ablation potentiates immunotherapy of AXL-specific CAR T cells against non-small cell lung cancer. Nat Commun 13:6203. https:\/\/doi.org\/10.1038\/s41467-022-33968-5","journal-title":"Nat Commun"},{"key":"4003_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202413181","author":"M Wang","year":"2024","unstructured":"Wang M, Sang J, Xu F et al (2024) Microwave ablation combined with Flt3L provokes tumor-specific memory CD8(+) T cells-mediated antitumor immunity in response to PD-1 blockade. Adv Sci (Weinh). https:\/\/doi.org\/10.1002\/advs.202413181","journal-title":"Adv Sci (Weinh)"},{"key":"4003_CR41","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000867","author":"ZS Buchwald","year":"2020","unstructured":"Buchwald ZS, Nasti TH, Lee J et al (2020) Tumor-draining lymph node is important for a robust abscopal effect stimulated by radiotherapy. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2020-000867","journal-title":"J Immunother Cancer"},{"key":"4003_CR42","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1146\/annurev-immunol-032712-095954","volume":"31","author":"SN Mueller","year":"2013","unstructured":"Mueller SN, Gebhardt T, Carbone FR, Heath WR (2013) Memory T cell subsets, migration patterns, and tissue residence. Annu Rev Immunol 31:137\u2013161. https:\/\/doi.org\/10.1146\/annurev-immunol-032712-095954","journal-title":"Annu Rev Immunol"},{"key":"4003_CR43","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.it.2021.08.002","volume":"42","author":"K Yang","year":"2021","unstructured":"Yang K, Kallies A (2021) Tissue-specific differentiation of CD8(+) resident memory T cells. Trends Immunol 42:876\u2013890. https:\/\/doi.org\/10.1016\/j.it.2021.08.002","journal-title":"Trends Immunol"},{"issue":"4049\u201366","key":"4003_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.09.020","volume":"185","author":"Q Huang","year":"2022","unstructured":"Huang Q, Wu X, Wang Z et al (2022) The primordial differentiation of tumor-specific memory CD8(+) T cells as bona fide responders to PD-1\/PD-L1 blockade in draining lymph nodes. Cell 185(4049\u201366):e25. https:\/\/doi.org\/10.1016\/j.cell.2022.09.020","journal-title":"Cell"},{"key":"4003_CR45","doi-asserted-by":"publisher","first-page":"4665","DOI":"10.1038\/s41467-024-49059-6","volume":"15","author":"X Tang","year":"2024","unstructured":"Tang X, Mao X, Ling P et al (2024) Glycolysis inhibition induces anti-tumor central memory CD8(+)T cell differentiation upon combination with microwave ablation therapy. Nat Commun 15:4665. https:\/\/doi.org\/10.1038\/s41467-024-49059-6","journal-title":"Nat Commun"},{"key":"4003_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202305832","volume":"11","author":"T Gao","year":"2024","unstructured":"Gao T, Yuan S, Liang S, Huang X, Liu J, Gu P, Fu S, Zhang N, Liu Y (2024) In Situ Hydrogel Modulates cDC1-based antigen presentation and cancer stemness to enhance cancer vaccine efficiency. Adv Sci (Weinh) 11:e2305832. https:\/\/doi.org\/10.1002\/advs.202305832","journal-title":"Adv Sci (Weinh)"},{"key":"4003_CR47","doi-asserted-by":"publisher","first-page":"4835","DOI":"10.1038\/s41467-020-18570-x","volume":"11","author":"Q Peng","year":"2020","unstructured":"Peng Q, Qiu X, Zhang Z et al (2020) PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade. Nat Commun 11:4835. https:\/\/doi.org\/10.1038\/s41467-020-18570-x","journal-title":"Nat Commun"},{"key":"4003_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101590","volume":"5","author":"Y Pan","year":"2024","unstructured":"Pan Y, Xue Q, Yang Y et al (2024) Glycoengineering-based anti-PD-1-iRGD peptide conjugate boosts antitumor efficacy through T cell engagement. Cell Rep Med 5:101590. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101590","journal-title":"Cell Rep Med"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-025-04003-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-025-04003-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-025-04003-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T06:48:51Z","timestamp":1745736531000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-025-04003-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":48,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["4003"],"URL":"https:\/\/doi.org\/10.1007\/s00262-025-04003-5","relation":{},"ISSN":["1432-0851"],"issn-type":[{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,25]]},"assertion":[{"value":"29 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"161"}}